Skip to content

PTSD research published in 2023

Page 5 of 5: studies 81 to 87 of 87, newest first. Back to the PTSD overview

Studies

Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions.

Frontiers in Psychiatry 2023 Macha Godes, Jasper Lucas, Eric Vermetten 14 citations

Post-traumatic stress disorder (PTSD) is a prevalent psychiatric condition that significantly impacts daily functioning in patients but lacks adequate treatment options. 3,4-methylenedioxymethamphetamine (MDMA) as an adjunct to psychotherapy for the treatment of PTSD has been studied increasingly for the last two decades and has shown promising results through quantitative data. However, few...

DOI: 10.3389/fpsyt.2023.957824 (opens in new tab) Full text (opens in new tab) PTSD MDMA-Assisted Psychotherapy Interpretative phenomenological analyses Psychedelics +1

Complementary and integrative interventions for PTSD.

European Journal of Psychotraumatology 2023 Barbara L Niles, Ariel J Lang, Miranda Olff 16 citations

ABSTRACTTo treat the impact of trauma, most current evidence supports the use of trauma-focused psychotherapy as the first line approach. However, millions of individuals exposed to trauma worldwide seek Complementary and Integrative Health (CIH) therapies in hopes of achieving wellness above and beyond reducing symptoms. But what is the evidence for CIH interventions? What are potential...

Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects.

Ibrain 2023 Bhuvi Sachdeva, Punya Sachdeva, Shampa Ghosh et al. 27 citations

Major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are the most common causes of emotional distress that impair an individual's quality of life. MDD is a chronic mental illness that affects 300 million people across the world. Clinical manifestations of MDD include fatigue, loss of interest in routine tasks, psychomotor agitation, impaired ability to focus, suicidal...

Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician's perspective.

Expert Review of Clinical Pharmacology 2023 Luke J. Ney, Wole Akosile, Chris Davey et al. 8 citations

Preclinical and experimental research have provided promising evidence that medicinal cannabis may be efficacious in the treatment of posttraumatic stress disorder (PTSD). However, implementation of medicinal cannabis into routine clinical therapies may not be straightforward. In this review, we describe some of the clinical, practical, and safety challenges that must be addressed for...

DOI: 10.1080/17512433.2023.2276309 (opens in new tab) Full text (opens in new tab) Cannabis Clinical medicine Exposure therapy Posttraumatic stress disorder

HEART RATE VARIABILITY AS AN OBJECTIVE CRITERION FOR THE PSYCHO-EMOTIONAL STATE OF COMBATANTS.

Wiadomosci lekarskie (Warsaw, Poland : 1960) 2023 Viktor S Matsyshyn, Anatolii M Kravchenko, Illya А Chaikovsky et al. 4 citations

The aim: To evaluate the functioning of the autonomic nervous system in combatants, the relationship between the heat rate variability (HRV) and ques¬tionnaire indicators, to improve the diagnosis of post-traumatic stress disorder (PTSD) and to evaluate the effectiveness of Transcendental Meditation (TM). Materials and methods: 57 combatants and 30 civilians, with registering ECG and...

Randomized controlled trials of mind-body interventions for posttraumatic stress disorder: a systematic review.

Frontiers in Psychology 2023 Josh Kaplan, Vanessa C Somohano, Belle Zaccari et al. 19 citations

Mind-body interventions (MBIs) include mindfulness-based interventions (MiBIs), meditation- and mantra-based interventions (MMIs), and movement-based interventions (MoBIs). These approaches have demonstrated preliminary efficacy in improving posttraumatic stress disorder (PTSD) symptoms. However, previous systematic reviews and meta-analyses have noted that this area of research is limited by...

DOI: 10.3389/fpsyg.2023.1219296 (opens in new tab) Full text (opens in new tab) Mindfulness Complementary integrative health Exercise Intervention +3

The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence.

Therapeutic Advances in Psychopharmacology 2023 Anya Ragnhildstveit, Jeremy Roscoe, Lisa C. Bass et al. 49 citations

Posttraumatic stress disorder (PTSD) is a devastating condition, for which there are few pharmacological agents, often with a delayed onset of action and poor efficacy. Trauma-focused psychotherapies are further limited by few trained providers and low patient engagement. This frequently results in disease chronicity as well as psychiatric and medical comorbidity, with considerable negative...

DOI: 10.1177/20451253231154125 (opens in new tab) Full text (opens in new tab) Clinical evidence Pharmacotherapy Rapid-acting antidepressant raad PTSD Therapy +2